Initial data from experiments using MSCs treatment in animal models of MS—experimental autoimmune encephalomyelitis (EAE)—were promising, showing reduction of inflammatory infiltrates and demyelination areas, stimulating oligodendrogenesis, and increased brain derived neurotrophic factor (BDNF) expression [4,5,6,7]. The gene discussed is BDNF; the disease is myeloid sarcoma.